Chapter 19. Huntington's Disease

  1. Mark Hallett4 and
  2. Werner Poewe5
  1. Kevin M. Biglan1,3 and
  2. Ira Shoulson2,3

Published Online: 29 OCT 2008

DOI: 10.1002/9780470713990.ch19

Therapeutics of Parkinson's Disease and Other Movement Disorders

Therapeutics of Parkinson's Disease and Other Movement Disorders

How to Cite

Biglan, K. M. and Shoulson, I. (2008) Huntington's Disease, in Therapeutics of Parkinson's Disease and Other Movement Disorders (eds M. Hallett and W. Poewe), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470713990.ch19

Editor Information

  1. 4

    Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA

  2. 5

    Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria

Author Information

  1. 1

    University of Rochester Medical Center, Movement and Inherited Neurological Disorders (MIND) Unit, Rochester, NY, USA

  2. 2

    University of Rochester Medical Center, Clinical Trials Coordination Center, Rochester, NY, USA

  3. 3

    University of Rochester, Department of Neurology, Rochester, NY, USA

Publication History

  1. Published Online: 29 OCT 2008
  2. Published Print: 17 OCT 2008

ISBN Information

Print ISBN: 9780470066485

Online ISBN: 9780470713990

SEARCH

Keywords:

  • Huntington's disease;
  • HD;
  • clinical characteristics;
  • epidemiology;
  • pathology;
  • pathogenesis;
  • experimental therapeutics

Summary

This chapter contains sections titled:

  • Clinical Characteristics

  • Epidemiology

  • Pathology

  • HD Pathogenesis

  • Experimental Therapeutics and Care

  • Summary

  • References